FDA wants feedback on how to regulate generative AI in medicine

The FDA's pursuit of public feedback signifies a pivotal shift toward formalizing safety guardrails for generative tools in clinical workflows. Establishing clear regulatory pathways will determine whether these models become reliable diagnostic assistants or potential liabilities in patient care.